BioOrbit receives £250,000 UK Space Agency feasibility study
46 FOMOThe UK Space Agency provided funding for a £250,000 feasibility study to develop a scalable in-orbit manufacturing system for crystallising biologic drugs used in cancer treatment. The study, funded through the Unlocking Space Portfolio, involves BioOrbit, the MHRA, and the UK Space Agency. It runs until March 2026 and is intended to clarify whether existing terrestrial pharmaceutical regulations apply to in-orbit manufacturing for patient use.
Why it matters
The study addresses a central commercial barrier for space pharmaceutical manufacturing: regulatory clarity. A favourable outcome would give BioOrbit a stronger path from demonstration experiments to patient-facing products.
The numbers
Coverage
-
ADS Group ·
Collaboration to support in-orbit pharmaceuticals manufacturingThe UK Space Agency awarded BioOrbit a £250,000 feasibility study under its Unlocking Space Portfolio to define the regulatory pathway for manufacturing pharmaceuticals in orbit. BioOrbit, the MHRA, and the UK Space Agency will assess whether existing terrestrial pharmaceutical regulations apply to in-orbit production for patient use.
AI-assisted summary of 1 report; numbers link to their source. Spot an error? Tell us.
More from BioOrbit
- BioOrbit · Mission 72
BioOrbit completes six-week ISS protein-crystallisation experiment
- BioOrbit · Funding 83
BioOrbit raises £9.8 million seed round
Related moments
- Jet Propulsion Laboratory · Contract 96
NASA opens JPL management contract to competitive procurement
- Sagittarius Logistics · Regulatory 2
Sagittarius Logistics completes SAM.gov registration
- Australian Space Agency · Partnership 5
Australian Space Agency and CASA sign safety MoU
- Air · Regulatory 19
Space Force awards Ark IL5 ATO
- Sierra Space · Regulatory 19
Sierra Space receives FAA reentry license for Dream Chaser
- Thales Alenia Space · Contract 83
Thales Alenia Space and Airbus win IRIS French military optical satellite contract
Veenie.Space Telemetry
The UK Space Agency provided funding for a £250,000 feasibility study to develop a scalable in-orbit